1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-2-oxopyridine-4-carbonitrile;1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-4-(2H-tetrazol-5-yl)pyridin-2-one
C42H43N17O2S2 — CID 159601548
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-2-oxopyridine-4-carbonitrile;1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-4-(2H-tetrazol-5-yl)pyridin-2-one
1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-2-oxopyridine-4-carbonitrile;1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-4-(2H-tetrazol-5-yl)pyridin-2-one (PubChem CID 159601548) has the molecular formula C42H43N17O2S2 and a molecular weight of 882.06 g/mol. Its IUPAC name is 1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-2-oxopyridine-4-carbonitrile;1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-4-(2H-tetrazol-5-yl)pyridin-2-one.
Molecular Properties
| Compound Name | 1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-2-oxopyridine-4-carbonitrile;1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-4-(2H-tetrazol-5-yl)pyridin-2-one |
|---|---|
| PubChem CID | 159601548 |
| Molecular Formula | C42H43N17O2S2 |
| Molecular Weight | 882.06 g/mol |
| Exact Mass | 881.32 |
| IUPAC Name | 1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-2-oxopyridine-4-carbonitrile;1-[6-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)amino]cyclopentyl]amino]-3-pyridinyl]-4-(2H-tetrazol-5-yl)pyridin-2-one |
| SMILES | CSc1cnc(N[C@H]2CC[C@H](Nc3ccc(-n4ccc(-c5nn[nH]n5)cc4=O)cn3)C2)nc1.CSc1cnc(N[C@H]2CC[C@H](Nc3ccc(-n4ccc(C#N)cc4=O)cn3)C2)nc1 |
| InChI | InChI=1S/C21H22N10OS.C21H21N7OS/c1-33-17-11-23-21(24-12-17)26-15-3-2-14(9-15)25-18-5-4-16(10-22-18)31-7-6-13(8-19(31)32)20-27-29-30-28-20;1-30-18-12-24-21(25-13-18)27-16-3-2-15(9-16)26-19-5-4-17(11-23-19)28-7-6-14(10-22)8-20(28)29/h4-8,10-12,14-15H,2-3,9H2,1H3,(H,22,25)(H,23,24,26)(H,27,28,29,30);4-8,11-13,15-16H,2-3,9H2,1H3,(H,23,26)(H,24,25,27)/t14-,15-;15-,16-/m00/s1 |
| InChIKey | MLNVZNHLFTZAJH-MESCZJBLSA-N |
| XLogP | 5.43 |
| TPSA | 247.71 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 882.06 |
| LogP ≤ 5 | 5.43 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159601548 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.